Hi-Tech Pharmacal receives FDA approval for bromfenac ophthalmic solution

The U.S. Food and Drug Administration has approved the abbreviated new drug application for once-daily bromfenac ophthalmic solution 0.09%, according to a press release from Hi-Tech Pharmacal. Bromfenac is used to treat inflammation and ocular pain after cataract surgery. Hi-Tech plans to immediately launch the generic drug.

Full Story →